Medicare Enrolled
Dr. Richard Schuman, MD
Hematology & Oncology · Edison, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Schuman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schuman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Schuman
Dr. Richard Schuman is a hematology & oncology specialist in Edison, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Schuman performed 25,922 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Schuman received a total of $4,133 from 52 pharmaceutical and/or device companies across 132 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Schuman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 27% volume in NJ
$4,133 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗25,922
Medicare services
Top 27% in NJ for hematology & oncology
Not available
Unique patients (not deduplicated)
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
10,500 | $1 | $3 |
| Pembrolizumab injection (Keytruda) | 6,600 | $41 | $161 |
| Denosumab injection (Prolia/Xgeva) | 3,900 | $18 | $68 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,012 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
640 | $100 | $422 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
604 | $8 | $30 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
476 | $8 | $23 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
465 | $67 | $245 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
354 | $6 | $14 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
338 | $12 | $48 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
167 | $25 | $101 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
161 | $118 | $462 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
158 | $149 | $589 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
103 | $1 | $6 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
92 | $58 | $227 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
77 | $14 | $54 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
56 | $1 | $3 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
50 | $74 | $299 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 42 | $346 | $1,464 |
| New patient office visit, complex (60-74 min) | 40 | $181 | $720 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
31 | $103 | $429 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
23 | $102 | $365 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
21 | $147 | $601 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $130 | $544 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
42.1% high complexity
46.8% medium
11.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,133
Total received (2018-2024)
Avg $590/year across 7 years
Top 44% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
132
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$634
2023
$703
2022
$490
2021
$12
2020
$160
2019
$479
2018
$1,654
Payments by company (2024)
Aveo Pharmaceuticals, Inc.
$133
Novartis Pharmaceuticals Corporation
$44
Blueprint Medicines Corporation
$40
PFIZER INC.
$37
Gilead Sciences, Inc.
$35
Regeneron Healthcare Solutions, Inc.
$34
Lilly USA, LLC
$31
Incyte Corporation
$30
Apellis Pharmaceuticals, Inc.
$25
Daiichi Sankyo Inc.
$25
GlaxoSmithKline, LLC.
$24
Mirati Therapeutics, Inc.
$20
Bayer Healthcare Pharmaceuticals Inc.
$20
Merck Sharp & Dohme LLC
$19
Alexion Pharmaceuticals, Inc.
$19
AstraZeneca Pharmaceuticals LP
$17
Pharmacosmos Therapeutics Inc.
$17
ARRAY BIOPHARMA INC
$17
Amgen Inc.
$16
Celgene Corporation
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Top 3 companies account for 34.4% of 2024 payments
All-time payments by company (2018-2024) ›
Puma Biotechnology, Inc.
$1,157
Amgen Inc.
$290
Daiichi Sankyo Inc.
$154
Blueprint Medicines Corporation
$154
Karyopharm Therapeutics Inc.
$150
Novartis Pharmaceuticals Corporation
$148
Exelixis Inc.
$146
Aveo Pharmaceuticals, Inc.
$133
Epizyme, Inc.,
$125
Avanir Pharmaceuticals, Inc.
$118
Gilead Sciences, Inc.
$114
PFIZER INC.
$109
Alexion Pharmaceuticals, Inc.
$94
Genentech USA, Inc.
$82
Celgene Corporation
$79
Astellas Pharma US Inc
$72
GENZYME CORPORATION
$62
Lilly USA, LLC
$60
Janssen Scientific Affairs, LLC
$48
Janssen Biotech, Inc.
$45
Incyte Corporation
$45
Sirtex Medical Inc
$43
AstraZeneca Pharmaceuticals LP
$43
Boehringer Ingelheim Pharmaceuticals, Inc.
$42
E.R. Squibb & Sons, L.L.C.
$39
Pharmacosmos Therapeutics Inc.
$38
GlaxoSmithKline, LLC.
$38
Ipsen Biopharmaceuticals, Inc
$35
Regeneron Healthcare Solutions, Inc.
$34
Eisai Inc.
$32
Bayer HealthCare Pharmaceuticals Inc.
$32
EISAI INC.
$29
Merck Sharp & Dohme Corporation
$29
Apellis Pharmaceuticals, Inc.
$25
Spectrum Pharmaceuticals Inc.
$23
Mirati Therapeutics, Inc.
$20
Bayer Healthcare Pharmaceuticals Inc.
$20
Merck Sharp & Dohme LLC
$19
Dendreon Pharmaceuticals LLC
$18
ARRAY BIOPHARMA INC
$17
Genmab U.S., Inc.
$17
Emmaus Medical, Inc.
$16
Verastem, Inc.
$15
Foundation Medicine, Inc.
$15
Pharmacyclics LLC, An AbbVie Company
$15
Jazz Pharmaceuticals Inc.
$15
MEDIVATION FIELD SOLUTIONS LLC
$14
Clovis Oncology, Inc.
$14
Rigel Pharmaceuticals, Inc.
$14
TOLMAR Pharmaceuticals, Inc.
$13
EMD Serono, Inc.
$11
Itamar Medical Inc
$10
Top 3 companies account for 38.7% of all-time payments
Associated products mentioned in payments ›
ALIMTA · AYVAKIT · Alecensa · BAVENCIO · Bavencio · Blincyto · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · ELIGARD · ELIQUIS · ENHERTU · Empaveli · Endari · Enhertu · Epkinly · FOTIVDA · FOUNDATIONONE · GAZYVA · GILOTRIF · IBRANCE · IMFINZI · Imbruvica · Inrebic · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LORBRENA · LUMAKRAS · Lenvima · MONOFERRIC · Nerlynx · Neulasta · Nplate · Nubeqa · ONZETRA Xsail · OPDIVO · OPDUALAG · Onivyde · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Perjeta · Pomalyst · REBLOZYL · ROLVEDON · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIMPONI ARIA · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · STRENSIQ · Stivarga · TAZVERIK · Tavalisse · Trodelvy · ULTOMIRIS · Ultomiris · VERZENIO · VYXEOS · Venclexta · WatchPATONE · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
433
County median income
$109,028
Nearest hospital to ZIP centroid (approximate)
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL AT RAHWAY
4.9 mi
4.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Schuman is a mixed practice specialist, with above-average Medicare volume (top 27% in NJ), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Schuman experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Schuman performed 10,500 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Schuman receive payments from pharmaceutical companies?
Yes. Dr. Schuman received a total of $4,133 from 52 companies across 132 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schuman's costs compare to other hematology & oncology specialists in Edison?
Dr. Schuman's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schuman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Edison
Browse hematology & oncology specialists in Edison ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
Puma Biotechnology, Inc. Payments to Doctors
See all physicians who received payments from Puma Biotechnology, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology